A randomized clinical trial to prevent recurrent CA-MRSA infection

Journal of Drugs in Dermatology, March, 2008

Sponsors and Collaborators: Los Angeles Biomedical Research Institute Kaiser Permanente. This clinical trial tests the hypotheses that 1) body decolonization of patients with recurrent community-associated methicillin-resistant Staphyloccus aureus (CA-MRSA) skin infections and their household members and 2) environmental decolonization of the patients' households will significantly reduce the likelihood of recurrent CA-MRSA infection.

Condition                Intervention                         Phase

Methicillin Resistant    Drug: mupirocin and chlorhexidine    Phase III
  Staphylococcus Aureus  Behavioral: household cleaning and
  Skin Infections          disinfection
                         Drug: mupirocin, chlorhexidine, and
                           household cleaning/disinfection

Study ID Numbers: 12550-01, KPSC IRB: 4714, CDC: 1U01CI000384-01

ClinicalTrials.gov Identifier: NCT00560599